You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Type III/IV afferents

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dental Implant Trial (Type I Dental implant placement., Type II Dental implant placement., Type III/IV dental implant

Not yet recruiting
  • Dental Implant
  • Type I Dental implant placement.
  • +2 more
  • (no location specified)
Aug 4, 2023

Ovarian Cancer Trial (Huaier granule)

Not yet recruiting
  • Ovarian Cancer
  • Huaier granule
  • (no location specified)
Feb 28, 2023

Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)

Recruiting
  • Immunotherapy
  • Gastrict Cancer
  • Fuzhou, China
    Fujian cancer hospital
Jan 17, 2023

Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)

Not yet recruiting
  • Immunotherapy Gastrict Cancer
  • (no location specified)
Jan 17, 2023

Osteogenesis Imperfecta Trial in Albuquerque (Setrusumab)

Recruiting
  • Osteogenesis Imperfecta
  • Setrusumab
  • Albuquerque, New Mexico
    New Mexico Clinical Research & Osteoporosis Center
Jul 29, 2022

Hip Arthropathy, Hip Dysplasia Trial in Istanbul (Shortened hip arthroplasty)

Recruiting
  • Hip Arthropathy
  • Hip Dysplasia
  • Shortened hip arthroplasty
  • İstanbul, Fatih, Turkey
    Bezmialem Vakıf University
Dec 3, 2021

Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial in Seoul (Oregovomab, Bevacizumab,

Recruiting
  • Ovarian Cancer by FIGO Stage
  • +2 more
  • Oregovomab
  • +3 more
  • Daegu, Korea, Republic of
  • +5 more
Oct 20, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Osteogenesis Imperfecta, Type I, Osteogenesis Imperfecta Type III, Osteogenesis Imperfecta Type IV Trial in Worldwide

Completed
Has Results
  • Osteogenesis Imperfecta, Type I
  • +2 more
  • Birmingham, Alabama
  • +24 more
Feb 7, 2022

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors

Not yet recruiting
  • Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
  • HX008 + TACE
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer hospital
Dec 8, 2022

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Epithelial Ovarian Cancer, Ovarian Cancer, Ovarian Cancer Stage III Trial (Niraparib)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • +3 more
  • (no location specified)
Jan 10, 2022

Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Biopsy
  • +2 more
  • Bethesda, Maryland
  • +2 more
Jan 25, 2023

Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)

Active, not recruiting
  • Skeletal Abnormalities
  • Psychomotor Retardation
    • Cairo, Egypt
    • +4 more
    May 12, 2021

    Neuregulin-4 and Its Receptor ErbB4 in Periodontitis and Without

    Recruiting
    • Periodontitis
    • Diabetes Mellitus
      • Cairo, Egypt
        Cairo university Faculty of dentistry
      Jun 17, 2021

      Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago

      Terminated
      Has Results
      • Pancreatic Adenocarcinoma
      • +2 more
      • Pembrolizumab
      • Wild-type Reovirus
      • Chicago, Illinois
        Northwestern University
      Sep 6, 2022

      Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

      Active, not recruiting
      • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
      • +27 more
      • Los Angeles, California
      • +2 more
      Aug 5, 2022

      Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in

      Not yet recruiting
      • Stage II Fallopian Tube Cancer AJCC v8
      • +33 more
      • Alpha-type-1 Polarized Dendritic Cells
      • Autologous Natural Killer Cell-like CTLs
      • Buffalo, New York
        Roswell Park Cancer Institute
      Apr 1, 2022

      Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (biological, procedure,

      Recruiting
      • Lung Adenocarcinoma
      • +2 more
      • Ipilimumab
      • +5 more
      • Conroe, Texas
      • +4 more
      May 25, 2022

      Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

      Not yet recruiting
      • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
      • +10 more
      • (no location specified)
      Jan 31, 2023

      Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

      Not yet recruiting
      • Anatomic Stage III Breast Cancer AJCC v8
      • +3 more
      • (no location specified)
      Jul 28, 2023

      Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)

      Recruiting
      • Stage IV Melanoma
      • Stage III Melanoma
      • Jette, Brussels, Belgium
        Universitair Ziekenhuis Brussel
      Sep 29, 2021

      Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

      Recruiting
      • Advanced Bladder Carcinoma
      • +34 more
      • Atezolizumab
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 29, 2022

      Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)

      Recruiting
      • Gastric Carcinoma Stage IV
      • Esophagogastric Junction Adenocarcinoma Stage IV
      • Moscow, Russian Federation
        Blokhin's Russian Cancer Research Center
      Apr 11, 2021

      Advanced Breast Adenocarcinoma, Advanced HER2-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8 Trial (Best

      Withdrawn
      • Advanced Breast Adenocarcinoma
      • +14 more
      • Best Practice
      • +3 more
      • (no location specified)
      Jun 7, 2022